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Pathogen-pathogen interactions in polymicrobial infections are known to directly impact,
often to worsen, disease outcomes. For example, co-infection with Pseudomonas
aeruginosa and Aspergillus fumigatus, respectively the most common bacterial
and fungal pathogens isolated from cystic fibrosis (CF) airways, leads to a
worsened prognosis. Recent studies of in vitro microbial cross-talk demonstrated that
P. aeruginosa-derived volatile sulfur compounds (VSCs) can promote A. fumigatus
growth in vitro. However, the mechanistic basis of such cross-talk and its physiological
relevance during co-infection remains unknown. In this study we combine genetic
approaches and GC-MS-mediated volatile analysis to show that A. fumigatus
assimilates VSCs via cysteine (CysB)- or homocysteine (CysD)-synthase. This process
is essential for utilization of VSCs as sulfur sources, since P. aeruginosa-derived VSCs
trigger growth of A. fumigatus wild-type, but not of a 1cysB1cysD mutant, on sulfur-
limiting media. P. aeruginosa produces VSCs when infecting Galleria mellonella and
co-infection with A. fumigatus in this model results in a synergistic increase in mortality
and of fungal and bacterial burdens. Interestingly, the increment in mortality is much
greater with the A. fumigatus wild-type than with the 1cysB1cysD mutant. Therefore,
A. fumigatus’ ability to assimilate P. aeruginosa derived VSCs significantly triggers a
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synergistic association that increases the pathobiology of infection. Finally, we show that
P. aeruginosa can promote fungal growth when growing on substrates that resemble the
lung environment, which suggests that this volatile based synergism is likely to occur
during co-infection of the human respiratory airways.
Keywords: P. aeruginosa – A. fumigatus interaction, co-infection, volatile sulfur compounds, volatile interaction,
interkingdom interaction, polymicrobial infection
INTRODUCTION
The filamentous fungus Aspergillus fumigatus and the bacterium
Pseudomonas aeruginosa are common respiratory pathogens.
Both are able to infect the lungs of immunosuppressed
individuals and also of patients with certain underlying diseases,
such as bronchiectasis, chronic obstructive pulmonary disease,
hospital acquired pneumonia and, particularly, cystic fibrosis
(CF). CF is the result of mutations in the CF transmembrane
conductance regulator (CFTR) gene, which encodes a chloride
channel. Dysfunction of this channel leads to a failure to
secrete chloride ions and to increased water absorption from
the airway epithelium, resulting in the formation of viscous
mucus that is resistant to mucociliary clearance. As a result, a
perfect environment for polymicrobial colonization is developed
(Ratjen and Doring, 2003).
Aspergillus fumigatus and Pseudomonas aeruginosa are,
respectively, the most prevalent fungal and bacterial pathogens
isolated from CF airways (Shoseyov et al., 2006; Amin et al., 2010;
Brandt et al., 2018). Recent studies have reported prevalences in
CF patients ranging from 31 to 46% for P. aeruginosa (Registry
CFFP, 2016, Registry UCF, 2016; Reece et al., 2017), up to 57%
for A. fumigatus (Bakare et al., 2003; Baxter et al., 2013a; Burgel
et al., 2016), and a prevalence of 15.8% for co-infection (Zhao
et al., 2018). Co-infection with both pathogens is associated
with a more rapid decline in CF pulmonary function and more
respiratory exacerbations, all leading to a worse prognosis (Amin
et al., 2010; Reece et al., 2017). Therefore, both pathogens should
be considered and targeted in order to improve CF patient
outcomes. In support of this, it was shown that an intravenous
antibiotic treatment targeting Pseudomonas could also reduce
the presence of Aspergillus in CF patient sputum. Treatment
translated into a greater improvement in the forced expiratory
volume in the first second (FEV1) for patients initially co-infected
than in those only infected with Pseudomonas (Baxter et al.,
2013b). To understand such cross effects and exploit them to
the patients’ benefit a profound insight of the pathogen-pathogen
interaction taking place during infection is required.
In the environment microbes constantly interact through
molecular signals, which can trigger synergistic and antagonistic
associations. Such interactions also occur during polymicrobial
infections, and are being increasingly recognized as important
pathogenicity factors (Singer, 2010; Peters et al., 2012). The
relevance of volatile organic compounds (VOCs), molecular
messengers that can exert long distance interactions (Schulz-
Bohm et al., 2017), has thus far been largely overlooked. However,
the fact that exhaled VOCs are promising diagnostic biomarkers
for a number of infections (Ahmed et al., 2017) demonstrates that
pathogenic microbes produce these molecules in human tissues,
which suggests that they may be at sufficient levels to mediate
microbial cross-talk during polymicrobial infections.
Recently, it has been reported that P. aeruginosa-derived
dimethyl sulfide (DMS) enhances A. fumigatus growth in vitro,
which was proposed to be due to its exploitation as a sulfur source
(Briard et al., 2016). We had previously shown that A. fumigatus
can utilize volatile sulfur compounds (VSCs) as the sole sulfur
source (Amich et al., 2013). Therefore, in this study we aimed
to unravel the mechanistic basis of A. fumigatus assimilation
of VSCs, and the relevance of P. aeruginosa-derived VSCs for
pathogen-pathogen interactions in vivo.
RESULTS
A. fumigatus Assimilates VSCs via
Cysteine Synthase-(CysB) and
Homocysteine Synthase (CysD)
Incorporation of Sulfide
We previously demonstrated that VSCs are produced from
the catabolism of methionine (but not from other sulfur
sources, Supplementary Figure S1A) and can be assimilated
and exploited as the sole sulfur source (Amich et al., 2013).
However, it remains unknown whether sulfur acquisition via
VSCs is reliant upon gaseous or soluble sources. Aiming to
discern between VSC uptake from media or air A. fumigatus
was cultured on methionine-containing media, in the inner of
two concentrically positioned agar plates, for 3 days to promote
VSC absorption into sterile S-depleted distal media. At day 3,
the inner plate was removed and the outer S-depleted medium
ventilated to ensure elimination of any volatiles, after which
A. fumigatus was inoculated. In this experimental set-up, fungal
growth should only occur if the VSCs had been absorbed
in the agar media. However, no fungal growth was observed
(Supplementary Figure S1B), which suggests that A. fumigatus
likely assimilates VSCs directly from the air.
To precisely identify the VSCs that serve as S-sources,
we grew the fungus on minimal medium containing sulfate
or methionine as the sole sulfur source and sampled in the
headspace of petri dishes using solid-phase microextraction
(SPME) and gas chromatography mass spectrometry (GC-MS)
(Labows et al., 1980). No VSCs were detected when measuring
headspace samples from sterile media. Five major VSCs were
present in headspaces sampled from methionine- but not
sulfate-cultured A. fumigatus (Figure 1) and their production
occurred independently of nitrogen metabolism (Figure 1).
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FIGURE 1 | Gas chromatography mass spectrometry (GC-MS) identifies 5 major VSCs produced from Aspergillus fumigatus catabolism of methionine. A. fumigatus
was cultured for 3 days on various solid media before the headspace was analyzed using solid-phase microextraction (SPME) and gas chromatography mass
spectrometry (GC-MS) to detect VSCs. (A) Chromatogram showing the peaks for the 5 VSCs. These volatiles are produced only on methionine (not on sulfate) and
independently of the nitrogen source (ammonium or glutamine). The exact VSCs could be identified and their names and formula are shown. (B) Quantification of
Absorption Units for each of the volatiles in three biological replicates.
VSC2 (dimethyl sulfide, DMS) and VSC3 (dimethyl disulfide,
DMDS) were previously described to be exploited as S-sources
when produced by P. aeruginosa (Briard et al., 2016). VSC4
(dithiapentane, DTP) is likely degraded to DMDS (Bellesia et al.,
1996), and thus its assimilation likely follows the same route.
VSC5 (2-methylthiolan-3-one, MTO) is possibly derived from
homocysteine catabolism (Nawrath et al., 2010), but since growth
on homocysteine does not trigger distal growth on S-free medium
(Supplementary Figure S1A), it is unlikely to be utilized as a
major volatile S-source. DMS and DMDS can both be degraded
to methanethiol (VSC1), either by a DMDS reductase (Smith and
Kelly, 1988), or a DMS monooxygenase (De Bont et al., 1981).
Sulfur from methanethiol (MT) could then be assimilated into
the metabolism through two different routes. It may be degraded
to formaldehyde, hydrogen peroxide, and sulfide by the action
of MT oxidase (Suylen et al., 1987; Gould and Kanagawa, 1992),
and therefore sulfide (S2−) would be incorporated into cysteine
by the action of CysB or to homocysteine by the action of CysD
(Figure 2A). As an alternative route, MT has also been described
to be entirely added to O-acetylhomoserine by the action of CysD
to directly yield methionine, bypassing the methionine synthase
dependent methylation of homocysteine (Bolten et al., 2010;
Figure 2A).
To elucidate the assimilation route, we constructed mutant
strains deleted in genes that are required for each pathway and
investigated their ability to grow on S-free media when exposed to
VSCs derived from methionine catabolism or to pure DMDS and
DMS (Figure 2B). If CysD was the only gene product responsible
for MT assimilation, a 1cysD mutant should not be able to grow
on S-free media; however, this strain showed some distal growth
(Figure 2B), proving that CysB can also incorporate volatiles
and therefore that the MT oxidase route is active. Given that
we could not identify any obvious orthologs of MT oxidases
described in other microorganisms in A. fumigatus’ genome,
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FIGURE 2 | VSCs are incorporated into the trans-sulfuration pathway by the action of CysB and CysD. (A) Outline of the possible routes for VSCs assimilation.
Sulfide could be liberated from methanethiol (MT) by an MT oxidase action and incorporated into the metabolism through the action of CysB or CysD. Alternatively,
MT could be directly incorporated into homocysteine by CysD to yield methionine, bypassing the requirement of MetH (cysB, cysteine synthase; cysD, homocysteine
synthase; metH, methionine synthase; metF, methyl-tetrahydrofolate reductase). (B) Aspergillus derived VSCs and pure DMDS and DMS were not able to trigger
growth of a 1metF strain. The volatiles triggered growth of the single 1cysB and 1cysD mutant strains, although to a much lesser extent than the wild-type, but did
not trigger growth of the double 1cysB1cysD mutant. ∼8.5 µg of DMS and ∼10.5 µg of DMDS were added every 12 h (5×) to the filter disk in the inner plate.
(C) The use of Hydrogen Sulfide Test Strips, which turn dark upon contact with H2S, detected that A. fumigatus produces low amounts of sulfide (comparable to
that liberated from ∼0.077 mg of Na2S) from methionine catabolism. Sulfide released from the Na2S donor could not trigger growth of the distal A. fumigatus colony,
even if added in higher amounts or in repeated occasions (5 times, once every 12 h). All plates in (B,C) were incubated at 37◦C for 3 days.
we evaluated the MT oxidase activity potential of A. fumigatus
protein extracts by measuring the accumulation of formaldehyde
upon addition of MT and observed that indeed the fungus seems
to have MT oxidase activity (Supplementary Figure S2). To
determine if the alternative route is also active we constructed
a 1metF strain (Figure 2A) to induce a genetic blockade upon
the recycling of methylated tetrahydrofolate (CH3-THF), which
is required for methionine synthase-dependent methylation of
homocysteine. We noticed that 1metF grew very poorly on
MM supplemented with methionine, but did grow normally if
amino acids (aac) were supplemented (Supplementary Figure
S3A); this is not surprising as tetrahydrofolate (THF) mediates
the interconversion of serine and glycine and folates play a
role in histidine and aromatic amino acid metabolism (Lucock,
2000; Tzin and Galili, 2010). We observed that the 1metF strain
was not able to grow on volatiles, implying that the CysD
Frontiers in Microbiology | www.frontiersin.org 4 October 2019 | Volume 10 | Article 2311
fmicb-10-02311 October 5, 2019 Time: 15:53 # 5
Scott et al. P. aeruginosa – A. fumigatus Volatile Dependent Interaction in Co-infection
enzyme cannot bypass the MetF dependent requirement of CH3-
THF to synthesize methionine and therefore that the alternative
route is not active (Figure 2B). Finally, a 1cysB1cysD double
mutant could not grow on A. fumigatus derived or externally
added volatiles, whereas the single mutant strains 1cysB and
1cysD did grow, although to a much lower degree (Figure 2B).
This indicates that assimilation of VSCs must go through the
conversion of MT into sulfide and its subsequent incorporation
by CysD or CysB, and that both enzymatic actions are required
for efficient assimilation of S2−. Reintroduction of the CysB
encoding gene in the 1cysB1cysD strain reconstituted its ability
to grow on sulfate and to cross-feed from VSCs, demonstrating
that the growth defect of the double mutant is specific to the
mutations (Supplementary Figure S3B).
Therefore, A. fumigatus can use DMS and DMDS as the sole
S-sources by converting them to sulfide, which is assimilated
into the metabolism. This raises the question of whether H2S
may be solely responsible for the cross-feeding effect. Since our
instruments cannot detect H2S we used hydrogen sulfide test
strips to determine if this gas is produced by A. fumigatus and
a chemical donor (Na2S) to investigate its potential to cross-
feed a distal colony. We found that A. fumigatus does produce
low amounts of H2S when grown on methionine, but not on
sulfate (Figure 2C). However, a distal A. fumigatus colony could
not cross-feed from pure sulfide, even if we attempted higher
amounts of the compound and also adding it on repeated
occasions (Figure 2C). We could differentiate between the
absence of cross-feeding effects and the toxicity of H2S as the
addition of the highest concentrations used (5 × 0.0154 mg
and 5 × 0.077 mg) caused the disappearance of the background
residual growth (Figure 2C).
P. aeruginosa Derived VSCs Are
Exploited as S-Sources by A. fumigatus,
Promoting Its Growth on Low
Concentrations of Organic Sulfur
It has recently been reported that P. aeruginosa promotes
A. fumigatus distal growth in vitro through the production of
DMS (Briard et al., 2016). To determine if the exploitation of
VSCs as a sulfur source drives this stimulatory effect, we tested the
effect of P. aeruginosa VSCs on distal growth of A. fumigatus wild-
type and 1cysB1cysD strains (Figure 3). P. aeruginosa derived
VSCs triggered growth of wild-type Aspergillus, but not of the
1cysB1cysD mutant, on S-depleted media (Figure 3A). Actually,
the growth profile of the A. fumigatus mutants was identical to
that observed in Figure 2C, indicating that they are assimilated
through the same route. In contrast to A. fumigatus, P. aeruginosa
produced VSCs (i.e., triggered distal fungal growth) when the
medium contained an excess of sulfate, but not when it contained
an excess of methionine, even if the production of H2S was higher
from methionine (Figure 3A). This suggests that the bacterium
may be producing VSCs through a different mechanism and also
supports our previous observation that sulfide cannot be directly
exploited as an S-source.
Aspergillus fumigatus most likely encounters low
concentrations of organic S-compounds to exploit as S-sources
during its growth in living tissues (personal observations,
reference (Amich et al., 2016) and explained in discussion).
Therefore, we tested the capacity of P. aeruginosa derived VSCs
to enhance fungal growth on low concentrations of cysteine.
On very low cysteine (0.01 mM), both A. fumigatus wild-type
and 1cysB1cysD strains displayed limited growth; interestingly
P. aeruginosa derived VSCs significantly enhanced wild-type, but
not mutant, growth (Figure 3B). On mid-low cysteine (0.1 mM)
both A. fumigatus strains developed fully grown colonies at day 3
(Supplementary Figure S3C), but Pseudomonas derived volatiles
exclusively stimulated early growth (day 1.5) of the wild-type
strain (Figure 3C). These results show that A. fumigatus can
exploit VSCs and cysteine as S-sources simultaneously; therefore
the presence of VSCs can enhance fungal growth of the wild-type
strain in otherwise limiting conditions.
Contrary to the positive effect of P. aeruginosa-derived VSCs
on fungal growth, A. fumigatus derived VSCs from methionine
catabolism did not trigger P. aeruginosa growth on an S-depleted
plate (Supplementary Figure S4), indicating that P. aeruginosa
cannot assimilate these volatiles.
P. aeruginosa Produces VSCs Inside
Infected Galleria mellonella
To determine if P. aeruginosa produces VSCs when growing
inside Galleria, we actively sampled the headspace within
sealed flasks containing groups of ten infected or uninfected
larvae 24 h after infection and measured it using GC-MS
(Ahmed et al., 2018). We could detect a clear enrichment of
several VSCs specifically in the flasks containing infected larvae,
namely MT, DMS, DMDS, and dimethyl trisulfide (DMTriS)
(Figures 4A,B). This demonstrates that P. aeruginosa does
produce VSCs inside living Galleria during infection that can
potentially be exploited by A. fumigatus during co-infection. We
next tested if P. aeruginosa can trigger distal fungal growth from a
homogenized Galleria (solidified with agar). Indeed P. aeruginosa
inoculated on the “Galleria medium,” but not the medium alone,
triggered distal A. fumigatus growth on S-depleted medium
(Figure 4C). This proves that P. aeruginosa produces VSCs from
the molecules contained in the Galleria organism than can then
trigger distal fungal growth.
P. aeruginosa Derived VSCs Promote
A. fumigatus Growth in vivo, Which
Accounts for an Increase in Mortality
To elucidate the relevance of VSC for the in vivo A.
fumigatus – P. aeruginosa interaction, we developed a low-dose
co-infection model in Galleria mellonella. Titration of infectious
inocula of the A. fumigatus wild-type and 1cysB1cysD strains
determined that 50 conidia caused moderate mortality of 15%
(Supplementary Figure S5A). It is notable that 1cysB1cysD
mutant is as virulent as the wild-type (Supplementary Figure
S5A), proving that A. fumigatus exploits organic S-sources
inside the larvae. Titration of the infection inocula for the
P. aeruginosa clinical isolate ATCC 9027 showed that ∼10–
20 CFU caused ∼26.7% mortality and ∼1–5 CFU resulted in
∼100% survival (Supplementary Figure S5B). Co-infection with
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FIGURE 3 | Pseudomonas aeruginosa derived VSCs promote A. fumigatus growth in sulfur limiting conditions. (A) When P. aeruginosa (P.a) was inoculated on a
sulfate containing inner plate it was able to trigger distal growth of A. fumigatus wild-type, 1cysB, and 1cysD strains on the outer S-free plates. The 1metF and
1cysB1cysD strains could not utilize P. aeruginosa derived VSCs as a sulfur source. The use of H2S strips showed that P.a produced a small amount of H2S on
sulfate and more on methionine, but this could not cross-feed A. fumigatus. Plates were incubated at 37◦C for 3 days. (B) On media containing very low cysteine
(0.01 mM) as the sole S-source, both wild-type 1cysB1cysD strains displayed limited growth. P. aeruginosa derived VSCs significantly enhanced A. fumigatus
wild-type, not mutant, growth. Plates were incubated at 37◦C for 3 days. (C) Measurement of colony diameters at 36 h post-inoculation on media containing low
cysteine (0.1 mM) showed that P. aeruginosa derived VSCs significantly stimulated early A. fumigatus wild-type, not mutant, growth. Plates were incubated at
37◦C for 36 h. ∗∗P < 0.01 and ∗∗∗P < 0.001.
50 conidia of A. fumigatus wild-type and both ∼1–5 CFU
and ∼10–20 CFU of P. aeruginosa triggered a ∼45% increase
in mortality compared with the single infections (Figure 5A).
Thus, relative to monomicrobial infections, co-infection leads
to a threefold increase in mortality. Interestingly, co-infection
with 50 conidia of 1cysB1cysD and Pseudomonas resulted
in no increase in mortality for ∼1–5 CFU and of only 19%
for ∼10–20 CFU (Figure 5A), representing a maximum of
only a 1.4 fold increase in mortality. Actually, co-infection
with A. fumigatus wild-type was significantly more virulent
than with 1cysB1cysD: 92.5% vs. 64.1% mortality for ∼10–
20 P. aeruginosa CFU (P = 0.0046) and 73% vs. 27.1%
for ∼1–5 P. aeruginosa CFU (P = 0.001). To corroborate
the observed synergism, we also assayed co-infection using
the P. aeruginosa PAO1 reference strain. PAO1 was similarly
virulent as the clinical isolate ATCC 9027 (Supplementary
Figure S5C). In agreement with our previous result, co-
infection of ∼1–5 CFU Pseudomonas PAO1 with Aspergillus
wild-type synergistically increased mortality (2.8 fold with
respect to monomicrobial infections) whilst co-infection with
A. fumigatus1cysB1cysD enhanced mortality to a much lesser
extent (1.4 fold) (Figure 5B). Again, co-infection with Aspergillus
wild-type was significantly more virulent than co-infection with
the mutant (93.3% vs. 46.7%, P = 0.005). Reintroduction of
the CysB encoding gene in the double mutant background
(cysB + 1cysD) reconstituted the capacity of the strain to
cause highest mortality in co-infection with P. aeruginosa PAO1
(Figure 5B). These results confirm that co-infection worsens
Frontiers in Microbiology | www.frontiersin.org 6 October 2019 | Volume 10 | Article 2311
fmicb-10-02311 October 5, 2019 Time: 15:53 # 7
Scott et al. P. aeruginosa – A. fumigatus Volatile Dependent Interaction in Co-infection
FIGURE 4 | Pseudomonas aeruginosa produces VSCs inside infected Galleria, which are exploited as S-sources by A. fumigatus. Gas emitted from infected or
uninfected Galleria accumulated in the headspace of flasks and was sampled 24 h after infection and analyzed by GC-MS. (A) Chromatogram showing an overlay of
the peaks for an infected and an uninfected sample. (B) Relative normalized intensity (shown in logarithmic scale) of each of the VSCs peaks detected in two
independent experiments with five biological replicates. VSCs accumulated in the flask containing infected Galleria. (C) P. aeruginosa (P. a) growing on a solid
medium prepared from homogenized Galleria triggered distal A. fumigatus growth on sulfur depleted medium. Plates were incubated at 37◦C for 3 days.
the outcome of infection (i.e., enhances mortality) and suggests
that there is a synergistic effect between P. aeruginosa and
A. fumigatus which is significantly dependent on the fungal
exploitation of VSCs. To check if this synergy produces enhanced
fungal growth, as we had observed in vitro (Figure 3B), we
measured fungal burden at day 4 post-infection in single and
co-infected larvae by qPCR using a published quantification
method (Gago et al., 2014; Figure 5C). We observed a general
tendency toward increased fungal burden (∼0.25 genome
equivalents) in larvae co-infected with A. fumigatus wild-
type. Taking into account that several co-infected Galleria
had already succumbed, and so were not included but likely
would have had high burdens, we believe this increase is
relevant. We also observed a significantly increased bacterial
burden in Galleria co-infected with A. fumigatus wild-type,
suggesting a reciprocal synergistic effect of the fungus on
P. aeruginosa (Figure 5D).
P. aeruginosa Produces VSCs From
Artificial Sputum Medium (ASM) and
From Mucins
To better mimic the conditions that the pathogens encounter
in the airways of CF patients, we used a partially defined
medium with a composition that closely resembles CF
sputum (Kirchner et al., 2012). Both P. aeruginosa wild-
type strains ATCC 9027 and PAO1 were able to grow on ASM
and produced VSCs that triggered A. fumigatus wild-type,
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FIGURE 5 | Pseudomonas aeruginosa derived VSCs synergize with A. fumigatus in co-infection, increasing G. mellonella mortality. (A) A G. mellonella model of
infection with a low dose (50 conidia) of A. fumigatus (A. f) wild-type or 1cysB1cysD caused low mortality (27–30%). Infection with a low dose of P. aeruginosa
ATCC 9027 caused only 13.7% mortality for 1–5 CFU or 45% for 10–20 CFU. P. aeruginosa co-infection with Aspergillus wild-type dramatically increased mortality
to 73% for 1–5 CFUs and to 92.5% for 10–20 CFUs. In contrast, co-infection with the 1cysB1cysD mutant caused only a moderated increased in mortality to
27.1% for 1–5 CFUs and to 64.1% for 10–20 CFUs (Survival graph shows pool data of 3 independent experiments). (B) Co-infection of ∼1–5 CFU P. aeruginosa
PAO1 with A. fumigatus (A. f) wild-type caused a strong increase in mortality (from 26–33% in monomicrobial infections to 93.3%, 2.8 fold). In contrast, co-infection
with the A. fumigatus 1cysB1cysD mutant caused a much more moderate increase in mortality (to 46.7%, 1.4 fold). Reintroduction of the cysB gene in the
1cysB1cysD mutant (cySB + 1cysD) reconstituted the synergism of mortality of con-infection (84%) (Survival graph shows pool data of 3 independent
experiments). (C) Four days after infection, Galleria co-infected with A. fumigatus wild-type and P. aeruginosa ATCC 9027 showed a tendency toward having an
increased fungal burden and (D) had significantly higher bacterial burdens. ∗∗P < 0.05 and ∗∗∗P < 0.01.
Frontiers in Microbiology | www.frontiersin.org 8 October 2019 | Volume 10 | Article 2311
fmicb-10-02311 October 5, 2019 Time: 15:53 # 9
Scott et al. P. aeruginosa – A. fumigatus Volatile Dependent Interaction in Co-infection
but not 1cysB1cysD, distal growth on S-depleted media
(Figure 6A). A. fumigatus was able to grow on ASM, but did
not produce VSCs unless methionine was supplemented to the
medium (Figure 6A). Mucins are cysteine rich proteins and,
accordingly, both A. fumigatus wild-type and 1cysB1cysD
strains could exploit them as the sole S-source (Figure 6B),
but volatiles were not derived (Figure 6C). In contrast,
P. aeruginosa could produce VSCs from mucins that triggered
growth of the distally inoculated A. fumigatus wild-type
strain. Taken together, these results show that P. aeruginosa
produces VSCs from mucins contained in ASM that can
stimulate A. fumigatus growth, suggesting that bacterial
utilization of mucins may release an additional exploitable sulfur
source for the fungus.
FIGURE 6 | Pseudomonas aeruginosa produces VSCs from artificial sputum
medium (ASM) and from mucins. (A) Growth of P. aeruginosa ATCC 9027 and
PAO1 strains on ASM triggered distal A. fumigatus (A. f) growth. A. fumigatus
needed supplementation of methionine to the ASM medium to trigger distal
growth (i.e., to produce VSCs). (B) A. fumigatus wild-type and 1cysB1cysD
strains could exploit mucins as the sole sulfur source. (C) When grown on
mucins as the sole S-source wild-type P. aeruginosa, but not A. fumgiatus,
produced VSCs, which triggered distal A. fumigatus growth. Plates were
incubated at 37◦C for 3 days.
P. aeruginosa Can Cross-Feed
A. fumigatus When Growing on Murine
Lung Tissue and on Human Bronchial
Epithelial Cells
Aiming to determine if the observed synergistic effect may be
relevant for co-infection in humans, we tested the capacity
of P. aeruginosa to trigger distal A. fumigatus growth when
inoculated on substrates that replicate the lung. We first
inoculated P. aeruginosa directly on explanted diced murine
lungs and observed that indeed bacterial growth on the lung
tissues could trigger growth of distal A. fumigatus wild type, but
not 1cysB1cysD, on S-depleted media (Figure 7). A. fumigatus
was able to grow on diced lungs, but its growth did not cross-feed
a distally inoculated colony. We then inoculated P. aeruginosa on
human bronchial epithelial cells 16HBE and observed that the
bacteria is also able to trigger distal A. fumigatus wild-type, not
1cysB1cysD, growth when feeding exclusively from human cells
(Figure 7). A. fumigatus growth directly on cells was quite limited
and did not cross-feed the distal colony. In conclusion, the cross-
feeding effect took place when P. aeruginosa grew on substrates
that mimic the airways, indicating that the observed synergism is
likely to take place in human co-infection.
DISCUSSION
The relevance of pathogen-pathogen interactions in
polymicrobial infections is being more and more recognized
(Singer, 2010; Peters et al., 2012). However, A. fumigatus –
P. aeruginosa interactions in co-infection are largely
unknown. Several in vitro studies have reported negative
effects of P. aeruginosa on A. fumigatus (Kerr et al., 1999;
FIGURE 7 | Pseudomonas aeruginosa produces VSCs from substrates that
replicate the lung. Both A. fumigatus (A. f) and P. aeruginosa ATCC 9027 and
PAO1 strains could grow directly on explanted diced murine lungs and on
human bronchial epithelial cells (16-HBE), but only P. aeruginosa produced
volatiles that triggered distal growth of A. fumigatus on a sulfur-free plate.
Plates were incubated at 37◦C for 3 days.
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Mowat et al., 2010; Penner et al., 2016; Shirazi et al., 2016; Briard
et al., 2017; Sass et al., 2018). However, clinical evidence suggests
the opposite, indicating a synergistic association in vivo. For
instance, a longitudinal study in adolescents with CF found
that A. fumigatus was the only species associated with an
increased risk for infection with P. aeruginosa (Hector et al.,
2016) and another recent study showed that P. aeruginosa
infection in CF patients was associated with higher incidence
of subsequent Aspergillus infection (Granchelli et al., 2018).
In addition, antibiotic treatment targeting Pseudomonas has
been observed to reduce Aspergillus’ presence in CF patient’s
sputum (Baxter et al., 2013b). Most of the negative effects
described in vitro were observed when setting the pathogens
in direct contact. However, given the size of the human lungs,
we speculate that the organisms likely occupy physically
separated niches, and therefore the action of long distance
acting molecules should be very relevant. Surprisingly, despite
the increasing number of studies investigating pathogen-
pathogen interactions, the role of volatiles in intermicrobial
cross-talk in vivo has been largely overlooked. Recently it
has been described that the Pseudomonas derived volatile
sulfur compound DMS promotes A. fumigatus growth in vitro
(Briard et al., 2016). In this study we have scrutinized the
pathway for VSCs assimilation in A. fumigatus and explored
the hypothesis that Pseudomonas derived VSCs could be
utilized by A. fumigatus in vivo, producing a synergistic effect
in co-infection.
We have shown that A. fumigatus assimilates VSCs through
the action of CysB (cysteine synthase) or CysD (homocysteine
synthase). The double mutant 1cysB1cysD cannot feed from
inorganic sources (nor incorporate VSCs), but is completely
virulent in both the G. mellonella and leukopenic murine
models of infection (Supplementary Figures S5A, S6A). This
strongly suggests that A. fumigatus predominately feeds from
organic S-sources within the tissues of both the larvae and
the mammalian lung. We have shown that in the Galleria
model, co-infection of P. aeruginosa with wild-type A. fumigatus
enhances virulence to a greater extent than co-infection with
the 1cysB1cysD strain. It has been recently described that
co-infection triggers a more pronounced pro-inflammatory
response (Bergeron et al., 2017); indeed Bergeron et al. (2017)
found a stronger immune response in Candida albicans –
P. aeruginosa co-infection, which they proposed could be the
reason of the observed increment in virulence and mortality.
Therefore, it could be argued that in our model a stronger
inflammatory response accounts for the increased mortality of
co-infection, and that the double mutant is more sensitive to
such hyperinflammation. However, a conidiocidal assay using
human neutrophilic granulocytes showed that neutrophils kill
conidia of the wild-type and double mutant strains similarly
(Supplementary Figure S6B), indicating that the 1cysB1cysD
strain is not more susceptible to attack by immune effector
cells. Therefore, although a stronger pro-inflammatory response
is likely to play a role in the pathology of co-infection, it does
not explain the differences found between the A. fumigatus wild-
type and mutant strains. We have shown that P. aeruginosa
produces VSCs in vivo, which translates into an increased fungal
burden in G. mellonella larvae co-infected with A. fumigatus
wild-type, but not 1cysB1cysD. Interestingly, we have also
observed an enhanced bacterial burden in larvae co-infected with
wild-type, but not the mutant strain, Aspergillus. It has been
reported that A. fumigatus enhances P. aeruginosa production
of the virulence factor elastase (Smith et al., 2015). Similarly,
it has been shown that C. albicans triggers production of
P. aeruginosa virulence factors, which was suggested, is the
leading cause of mortality in co-infection (Trejo-Hernandez
et al., 2014). Consequently, we hypothesize that Pseudomonas
derived VSCs enhance fungal growth, which then somehow
stimulates bacterial growth and pathogenesis, contributing to
an increase in the mortality of co-infection. Very recently
Reece et al. (2018) have reported that P. aeruginosa causes
increased mortality in G. mellonella when infected 24 h after
a challenge with a non-lethal A. fumigatus dose. The authors
proposed that this effect is likely due to one of two options:
either the fungus is producing immunoregulatory toxins that
suppress the immune system of G. mellonella, making them
more susceptible to P. aeruginosa infection or the two species
interaction causes a more virulent infection. Even if we believe
they are not mutually exclusive and toxins may also play a
role, our results support the second hypothesis: inoculated
P. aeruginosa produces VSCs, which increases A. fumigatus
growth, and the presence of the fungus enhances bacterial
pathogenicity, all resulting in higher mortality. Interestingly, the
authors assayed various A. fumigatus and P. aeruginosa isolates
(reference strains and patient isolates) and observed different
effects depending on the strain combination of co-infection.
Although we have not made any attempt to address this, we
speculate it might be partially explained by subtle differences
in the volatile production capacities of the P. aeruginosa
isolates, and/or their responses to interactions that occur
in vivo.
We have observed in vitro that P. aeruginosa produces VSCs
in the presence of sulfate. It has been shown that P. aeruginosa
can feed from sulfate present in human respiratory tracts,
and that it can also use sulfate contained within mucins as
an S-source (Robinson et al., 2012). We have shown that it
produces VSCs when grown on Artificial Sputum Medium
and on mucins. G. mellonella hemolymph contains mucin-
like proteins (Li et al., 2002), which we speculate the bacteria
is exploiting as an S-source, which triggers VSCs production
inside the infected larvae. It had previously been described
that A. fumigatus is able to degrade mucins (Leger and Screen,
2000), and we have observed that the fungus can use them
as a sulfur source in vitro. This is most likely due to the
utilization of the enriched amino acid cysteine as the S-source,
as suggested by the capacity of the 1cysB1cysD mutant to
grow on mucins and the inability of the wild-type to produce
VSCs. However, the gene(s) required for utilization of the
sulfate contained within the mucins (which could be one or
several of the three arylsulphatases encoded by its genome:
AFUA_3G02290, AFUA_5G12940, and AFUA_8G02520) may
not be expressed in the presence of cysteine (Amich et al., 2013),
impeding its exploitation as an additional S-source. Therefore,
we propose that during co-infection P. aeruginosa liberates an
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otherwise non-accessible sulfur source in the form of VSCs,
which in turns makes the tissues less sulfur limiting for the
fungus and promotes its growth. An alternative explanation
could be that P. aeruginosa liberates and/or releases sulfate
or other inorganic sulfur sources, which could be assimilated
by A. fumigatus wild-type but not 1cysB1cysD. Although we
cannot reject this possibility, we believe it is unlikely because the
growth promoting effect would be restricted to the proximity of
bacterial cells and also because the genes of the sulfate reduction
assimilation pathway (required to assimilate inorganic S-sources)
are downregulated in the presence of organic S-compounds
(Amich et al., 2013).
Interestingly, we show that when P. aeruginosa grows on
substrates that resemble the lung, namely explanted murine
lungs and human bronchial epithelial cells, it can trigger distal
A. fumigatus growth. A recent analysis of bronchoalveolar
lavage fluid of CF patients detected sulfur-containing volatiles
specifically in P. aeruginosa infected patients (Nasir et al.,
2018). Therefore, it seems plausible that P. aeruginosa derived
VSCs are able to trigger the synergistic effect described
in this manuscript and be relevant for co-infection in
the human airways.
In conclusion, we report a volatile dependent synergistic effect
of Pseudomonas aeruginosa on A. fumigatus during co-infection
of G. mellonella that causes higher fungal and bacterial burdens,
resulting in increased mortality. This effect is likely relevant for
the pathogen-pathogen interaction in patients’ lungs and thus has
an impact on the outcome of co-infection.
MATERIALS AND METHODS
Strains, Media and Culture Conditions
The Escherichia coli strain DH5α (Woodcock et al., 1989) was
used for cloning procedures. Plasmid-carrying E. coli strains
were grown at 37◦C in LB liquid medium under selective
conditions (100 µg·mL−1 ampicillin, 50 µg·mL−1 kanamycin
or 10 µg·mL−1 gentamycin); Media was solidified with 1.5%
agar. All plasmid constructs used in the course of this study
are listed in Supplementary Table S1 and were generated using
the Seamless Cloning (Invitrogen) technology as previously
described (Amich et al., 2013, 2016).
The wild-type clinical isolate A. fumigatus strain ATCC 46645
served as reference recipient; gene knock-out derivative strains
of this isolate were generated using a standard protoplasting
protocol (Szewczyk et al., 2006). Once verified by Southern-blot,
the mutants were grown on xylose to activate the encoded beta-
recombinase, which self-excise the selection marker, a strategy
previously described (Amich et al., 2013, 2016) (Supplementary
Figure S7). Reversion of the cysB gene was directed to its natural
locus using homology flanking regions. Mutants were selected by
reconstitution of ability to grow on sulfate as sole sulfur source
and checked by PCR. A. fumigatus strains were generally cultured
on minimal medium (MM) (Amich et al., 2016) at 37◦C. For
selection in the presence of resistance markers 50 µg·mL−1 of
hygromycin B or 100 µg·mL−1 of pyrithiamine (InvivoGen) was
applied. In sulfur-free medium, MgCl2 substituted for MgSO4,
and a modified mixture of trace elements lacking any sulfate
salt was used. Artificial sputum medium (ASM) was prepared
as previously described (Kirchner et al., 2012) and solidified
with 1.5% agar.
Pseudomonas aeruginosa wild-type clinical isolate ATCC
9027 and reference strain PAO1 were used for cross-feeding
experiments and G. mellonella infections. Strains were routinely
grown on LB, which was supplemented with 5 mM methionine
or 2 mM Na2SO4 for some experiments. “Galleria medium” was
prepared by homogenizing a larva with sterile ultrapure water
on a 70 µm cell-strainer (Falcon) with the use of a syringe
plunger. This homogenate was mixed with agar (to 1.5% final
concentration), solidified, and illuminated with UV light for
10 min to reduce bacterial contamination. Murine lungs were
explanted from uninfected controls at the end of a different
experiment. 16HBE cells (Cozens et al., 1994) were seeded in
coated plates (NunclonTM Delta, ThermoFisher Scientific) with
Dulbecco’s Modified Eagle Medium (DMEM, Gibco R©) at a very
high density (>100% confluency), left overnight to adhere, and
then the medium was removed to inoculate P. aeruginosa directly
on the cells. For G. mellonella infection, one single colony
of an overnight grown plate was suspended in 1 mL NaCl
0.9%/Tween-20 0.002%. This solution was diluted serially to yield
the desired concentrations, as confirmed each time by plating the
dilutions on LB.
For cross-feeding experiments one colony of P. aeruginosa or
103 conidia of A. fumigatus were inoculated in the internal plate,
and 102 conidia of each A. fumigatus strain in the external petri
dish. Unless otherwise stated, plates were incubated at 37◦C for
3 days inside zip-closed plastic bags. Na2S, DMS, and DMDS
were purchased from Sigma and the amounts described in each
experiment were added directly to Whatman filter paper placed
inside the inner plate.
Extraction and Manipulation of Nucleic
Acids
Standard protocols of recombinant DNA technology were
carried out (Sambrook et al., 1989). Phusion R© high-fidelity DNA
polymerase (Thermo Fisher Scientific) was generally used in
polymerase chain reactions and essential cloning steps were
verified by sequencing. Fungal genomic DNA was prepared
following the protocol of Kolar et al. (1988) and Southern
analyses were carried out as described (Southern, 1975, 2006),
using the Amersham ECL Direct Labeling and Detection System R©
(GE Healthcare).
Detection of Volatile Sulfur Compounds
Derived From Aspergillus fumigatus
in vitro
Volatile sulfur compounds measurement was performed as
described (Briard et al., 2016). Briefly, 106 conidia per ml
A. fumigatus spores were inoculated in 5 mL of sulfur free MM
with 2 mM Na2SO4 or 5 mM methionine as sulfur source and
incubated in 40 mL vials with screw caps with a rubber/PTFE
septum for 3 days at 37◦C. Direct sampling was performed in the
headspace of culture vials using SPME fibers [2 cm composite
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coating carboxen/divinylbenzene/polydimethylsiloxane (Car/
DVB/PDMS)]. Vial septa were pierced with the needle of the
filament holder followed by fiber exposure for 30 min in the
incubator at 37◦C. Volatiles were injected into Agilent HP-5MS
GC-MS column (length 30 m, internal diameter 0.25 mm,
and film thickness 0.25 µm) using a Front SS Inlet He in
Pulsed Splitless mode.
MT Oxidase Activity
Aspergillus fumigatus protein extracts were isolated from ground
mycelia in lysis buffer (50 mM HEPES; 1% NP-40; 0.5 mM EDTA;
0.1% SDS; 1mM DTT) with 1× complete protease inhibitor
cocktail (Roche). 500 µM methanethiol was added or not to
0.5 mg protein extracts in 200 µl of lysis buffer and incubated
for 6 h at 37◦C in sealed tubes. Formaldehyde was measured
using Purplad R© reagent (Sigma) as previously described (Boden
et al., 2011). Briefly, 100 µl of a 34 mM dilution of Purpald R©
in 2 M NaOH was added to the tubes, incubated for 15 min
and OD measured at 550 nm. The increment in absorbance
was normalized with lysis buffer and converted to µM of
formaldehyde using a standard curve.
Galleria mellonella Infection
Sixth-stage instar larval G. mellonella moths (15 to 25 mm in
length) were ordered from the Live Foods Company (Sheffield,
United Kingdom). Infections were performed according to
Kavanagh and Fallon (2010). Randomly selected groups of 15
larvae were injected with 20 µl of NaCl 0.9%/Tween-20 0.002%
containing varying doses of A. fumigatus conidia or P. aeruginosa
CFUs, as detailed in each experiment. A. fumigatus was always
injected into the last right proleg, whilst P. aeruginosa was
always injected in the left proleg. Braun Omnican 50-U 100 0.5-
mL insulin syringes with integrated needles were used. In each
experiment an untouched and a saline injected control were
included, to verify that mortality was not due to the health status
of the larvae or the injection method.
Detection of Volatile Sulfur Compounds
Derived From Pseudomonas aeruginosa
in Infected Galleria
The headspace of flasks containing 10 G. mellonella uninfected or
infected with P. aeruginosa (5 flasks/group) were sampled after
a 24 h incubation at 37◦C, using a method described previously
(Ahmed et al., 2018). Briefly, a total volume of 200 mL was
sampled from a 100 mL glass flask containing Galleria, at a
flow of 100 mL/min, onto conditioned silco-treated stainless
steel multi-sorbent tubes packed TenaxTA/Carbograph5TD. This
sorbent bed was chosen to maximize the range of Volatile
Organic Compounds (VOCs) captured, whilst minimizing water
retention. Sorbent tubes were stored at 4◦C before analysis,
for up to 7 days.
Volatile organic compounds trapped onto the sorbent bed
were analyzed using thermal desorption-gas chromatography-
mass spectrometry (TD-GC-MS). In summary, sorbent tubes
underwent a two-stage thermal desorption process where the
initial desorption was carried out at 220◦C for 5 min. Prior
to this, an internal standard (1 ppmV 4-bromoflorobenzene
in N2) was injected onto each tube. VOCs were purged off
the tube using N2 and onto a cold trap (kept at 0◦C), which
was subsequently desorbed at 230◦C for 3 min. VOCs were
then transferred to the GC column at a constant flow of
2 mL/min using He as the carrier gas. The Agilent DB-1ms
GC column (length 60 m, internal diameter 0.25 mm, and film
thickness 0.5 µm) was housed within an Agilent 6890 GC oven
(Agilent Technologies, West Lothian, United Kingdom) which
underwent a ramped programs with an initial 40◦C temperature
(no hold), ramped to 250◦C (18 min hold) at 5◦C/min. The
total GC cycle time was 60 min. After separation by GC, VOCs
were transferred to a Waters GCT mass spectrometer (Waters
Corporation, Manchester, United Kingdom), equipped with an
EI + source (70 eV), and a time-of-flight mass analyzer. Data
were acquired between m/z 29–400 in centroid mode, at a
rate of 10 scans/s.
Data were analyzed by using Target Lynx (Masslynx software
version 4.1, Waters Corporation, Manchester, United Kingdom).
The exact masses of base peaks m/z 47, 62, 94, 126, and 158 were
used to extract methanethiol, dimethyl sulfide, dimethyl disulfide,
DMTriS, and dimethyl tetrasulfide, respectively, along with
retention indices calculated using alkane chemical standards (C5–
C15). Data were pre-processed using the Apex Trak algorithm
(Waters Corporation, Manchester, United Kingdom) which
included peak integration, smoothing and baseline correction.
Data were then normalized to the internal standard (with
an extracted base peak of m/z 174). DMS and DMDS were
identified to MSI level 1 standard (Fiehn et al., 2007), a NIST
library search was performed on the sample peak, together
with retention time matching of their counterpart external
standards. Other VSCs were identified to MSI level 2 i.e., NIST
library search only.
Neutrophil Killing Assay
Human neutrophils were isolated from healthy donors’ blood
using the EasySepTM Direct Human Neutrophil Isolation
Kit (StemCell) following the manufacturer’s instructions
for EasystepTM Magnets EasyEightsTM protocol. Purified
neutrophils were set in culture in RPMI medium (Sigma)
supplemented with 10% human serum (isolated from the same
donor’s blood by centrifugation at 1200 × g 4 min), and conidia
were added on top at a multiplicity of infection (MOI) ratio
of 1:10. After 6 h, medium was collected and centrifuged at
4,000 rpm for 5 min; the pellet was resuspended in distilled
water and finally resuspended in 1 ml 0.9% NaCl plus 0.01%
Tween 20. Different dilutions were plated onto MM + cysteine
in triplicates, and colony forming units were counted. For
input controls, the same amount of conidia were incubated in
RPMI + serum for 6 h without neutrophils and treated and
plated as the experimental conditions.
Leukopenic Murine Model of Pulmonary
Aspergillosis
The experiment was performed under United Kingdom Home
Office project license PPL70/7324 and approved by the University
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of Manchester Ethics Committee. Outbred CD1 male mice (22–
26 g) were purchased from Charles Rivers and left to rest for at
least 1 week before the experiment. Mice were allowed access
ad libitum to water and food throughout the experiment. Mice
were immunosuppressed with 150 mg/kg of cyclophosphamide
on days −3 and −1 and with 112 mg/kg cortisone acetate on
day −1. On day 0 mice were anesthetized with isofluorane
and intranasally infected with a dose of 105 conidia (40 µl of
a freshly harvested spore solution of 2.5 × 106 conidia/mL).
Immunosuppression was maintained by injecting 150 mg/kg
cyclophosphamide every 3 days (days + 2 and + 5) and survival
was followed for 7 days.
Statistical Analyses
All graphs were prepared using GraphPad Prism v7.04 software.
For statistical analysis of survival curves the Log-Rank test
was applied. In column graphs one-way ANOVA or Kruskal-
Wallis (depending on the distribution) were utilized to determine
differences among groups. Significance was considered when
∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
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